Halozyme Therapeutics, Inc. (HALO)
110.19
-0.57
(-0.51%)
USD |
NASDAQ |
Sep 04, 16:00
109.96
-0.23
(-0.21%)
After-Hours: 20:00
Halozyme Therapeutics Cash and Short Term Investments (Annual) : 142.82M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 142.82M |
| December 31, 2024 | 596.07M |
| December 31, 2023 | 336.00M |
| December 31, 2022 | 362.79M |
| December 31, 2021 | 740.92M |
| December 31, 2020 | 368.01M |
| December 31, 2019 | 421.26M |
| December 31, 2018 | 354.53M |
| December 31, 2017 | 469.21M |
| December 31, 2016 | 204.98M |
| December 31, 2015 | 108.34M |
| December 31, 2014 | 135.62M |
| December 31, 2013 | 71.50M |
| Date | Value |
|---|---|
| December 31, 2012 | 99.90M |
| December 31, 2011 | 52.83M |
| December 31, 2010 | 83.26M |
| December 31, 2009 | 67.46M |
| December 31, 2008 | 63.72M |
| December 31, 2007 | 97.68M |
| December 31, 2006 | 44.19M |
| December 31, 2005 | 19.13M |
| December 31, 2004 | 16.01M |
| December 31, 2003 | 0.0475M |
| December 31, 2002 | 0.0972M |
| December 31, 2001 | 0.0261M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Incyte Corp. | 3.581B |
| AVITA Medical, Inc. | 18.18M |
| BioCryst Pharmaceuticals, Inc. | 274.95M |
| Neurocrine Biosciences, Inc. | 1.480B |
| Iovance Biotherapeutics, Inc. | 296.98M |